Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F3PPB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,064
Award facts
- Contract value 100% obligated
- $82,063.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $82,063.54 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the company's comprehensive pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through the Defense Logistics Agency. The company's IDC with DLA Troop Support Medical enables the supply of a wide range of pharmaceutical products, specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare systems globally. This specific delivery order for Dupixent, an immunosuppressant biologic used in treating conditions such as atopic dermatitis, eczema, and asthma, demonstrates the contractor's capability to fulfill federal medical supply requirements through competitive procurement processes and maintains its role as a primary pharmaceutical supplier to the Department of Defense and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F3PPB?
SPE2DR26F3PPB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F3PPB worth?
The government has obligated $82,064 on SPE2DR26F3PPB.
Is contract SPE2DR26F3PPB an order under another contract?
Yes. SPE2DR26F3PPB is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3PPB competed?
The extent of competition for SPE2DR26F3PPB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award